Arrowhead Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.47 | -$0.47 | -$0.47 |
| Q2 2024 | 4 | -$0.53 | -$0.53 | -$0.53 |
| Q3 2024 | 11 | -$2.30 | $0.83 | -$0.97 |
| Q4 2024 | 7 | -$1.27 | -$1.27 | -$1.27 |
| Q1 2025 | 5 | -$1.29 | -$1.29 | -$1.29 |
| Q2 2025 | 5 | -$1.23 | -$1.23 | -$1.23 |
| Q3 2025 | 6 | -$1.14 | -$1.14 | -$1.14 |
Arrowhead Pharmaceuticals, Inc. Earnings Date And Information
Arrowhead Pharmaceuticals, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-1.38 earnings per share for the quarter, missing analysts' consensus estimates of $-0.58 by $0.8. The company had revenue of 0 for the quarter and had revenue of 240.74 M for the year. Arrowhead Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-1.92 diluted earnings per share) and currently has a price-to-earnings ratio of -4.65. Arrowhead Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 26th, 2024 based on prior year's report dates.
Arrowhead Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2024 | Q3 2024 | -$0.58 | -$1.38 | -0.8 | $52.87 M | $0 |
| 05/09/2024 | Q2 2024 | -$0.06 | -$1.02 | -0.96 | $0 | |
| 02/06/2024 | Q1 2024 | -$0.78 | -$1.24 | -0.46 | $3.55 M | |
| 11/29/2023 | Q4 2023 | -$0.70 | -$1.02 | -0.32 | $44.63 M | $16.10 M |
| 08/07/2023 | Q3 2023 | -$0.58 | -$0.96 | -0.38 | $45.42 M | $15.83 M |
| 05/02/2023 | Q2 2023 | -$0.64 | $0.46 | 1.1 | $146.27 M | |
| 02/06/2023 | Q1 2023 | $1.14 | -$0.39 | -1.53 | $62.55 M | |
| 11/28/2022 | Q4 2022 | -$0.57 | -$0.81 | -0.24 | $50.30 M | $31.58 M |
| 08/04/2022 | Q3 2022 | -$0.45 | -$0.67 | -0.22 | $45.75 M | $32.41 M |
| 05/10/2022 | Q2 2022 | -$0.08 | $0.42 | 0.5 | $151.81 M | |
| 02/02/2022 | Q1 2022 | -$0.22 | -$0.60 | -0.38 | $27.44 M | |
| 11/22/2021 | Q4 2021 | -$0.11 | -$0.61 | -0.5 | $42.19 M | $38.28 M |
| 08/05/2021 | Q3 2021 | -$0.08 | -$0.29 | -0.21 | $43.47 M | $45.89 M |
| 05/04/2021 | Q2 2021 | -$0.09 | -$0.26 | -0.17 | $32.81 M | |
| 02/04/2021 | Q1 2021 | $1.00 | -$0.20 | -1.2 | $21.30 M | |
| 11/23/2020 | Q4 2020 | $0.34 | -$0.47 | -0.81 | $57.76 M | $7.63 M |
| 08/05/2020 | Q3 2020 | -$0.07 | -$0.13 | -0.06 | $30.42 M | $27.38 M |
| 05/07/2020 | Q2 2020 | -$0.11 | -$0.20 | -0.09 | $23.53 M | |
| 02/05/2020 | Q1 2020 | -$0.01 | -$0.03 | -0.02 | $29.45 M | |
| 11/25/2019 | Q4 2019 | $0.16 | $0.12 | -0.04 | $40.98 M | $43.29 M |
Arrowhead Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Arrowhead Pharmaceuticals, Inc.'s earnings date?
Arrowhead Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 26th, 2024 based off last year's report dates.
-
How can I listen to Arrowhead Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Arrowhead Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Arrowhead Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Arrowhead Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Arrowhead Pharmaceuticals, Inc. generate each year?
Arrowhead Pharmaceuticals, Inc. (:ARWR) has a recorded annual revenue of $240.74 M.
-
How much profit does Arrowhead Pharmaceuticals, Inc. generate each year?
Arrowhead Pharmaceuticals, Inc. (:ARWR) has a recorded net income of $240.74 M. Arrowhead Pharmaceuticals, Inc. has generated $-1.92 earnings per share over the last four quarters.
-
What is Arrowhead Pharmaceuticals, Inc.'s price-to-earnings ratio?
Arrowhead Pharmaceuticals, Inc. (:ARWR) has a price-to-earnings ratio of -4.65 and price/earnings-to-growth ratio is 0.47.
